Targeted Sequencing using Custom NEBNext Direct Panels
Addressing common issues in next generation sequencing assays
Have you considered incorporating genomics into your clinical trial design? In this presentation, you will explore the key attributes of genomic assays in support of clinical development.
You will also be introduced to the NEBNext Direct methodology, which addresses common issues that plague next generation sequencing (NGS) assays.
Q2 Solutions offers a comprehensive suite of genomic services to help you design and execute smarter trials. Download our presentation to learn more.
Jennifer Sims, Ph.D., Manager, Assay Development, Translational Genomics